Oncology News | pharmaphorum

News

Autolus closes on EU okay for leukaemia cell therapy

The CHMP backed approval of Autolus' leukaemia CAR-T Aucatzyl, as well as drugs from GSK, Roche, SpringWorks, and others, at its May meeting.

News

ASCO 25: Can GLP-1 drugs reduce cancer risk?

A study has suggested the benefits of GLP-1 agonists could extend to a reduction in the risk of a slew of cancers associated with being overweight.

News

ASCO 25: Jazz, PharmaMar reveal SCLC survival data

Jazz and PharmaMar have revealed the overall survival data with their small-cell lung cancer drug Zepzelca, described as a 'milestone' in the disease.

News

ASCO 25: Roche places Itovebi marker in breast cancer

Roche's Itovebi has become the first PI3K inhibitor to extend survival in HR-positive, HER2-negative breast cancer with a PIK3CA mutation.

News

Mixed outcomes for pharma in big week for FDA adcomms

There was good news for Johnson & Johnson at this week's ODAC meetings, but not for Roche, UroGen, and Pfizer.

News

UK trumpets £1bn investment plan from BioNTech

BioNTech has said it will commit up to £1bn in investment in the UK over the next decade, in what has been described as a "template" for the sector.

Autolus closes on EU okay for leukaemia cell therapy

ASCO 25: Can GLP-1 drugs reduce cancer risk?

ASCO 25: Jazz, PharmaMar reveal SCLC survival data

ASCO 25: Roche places Itovebi marker in breast cancer

Mixed outcomes for pharma in big week for FDA adcomms

UK trumpets £1bn investment plan from BioNTech

CDC panel votes to scrap hepatitis B birth dose advice

How to meet your physicians where they are online

News

Editor's Picks